Org 24448
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Org 24448, covering 2012-07-06 to 2016-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia [Phase 2]